** Shares of Recce Pharmaceuticals RCE.AX fall 2.3% to A$0.420, their lowest since February 21, 2024
** Pharmaceutical co posts HY net loss attributable of A$7.7 million ($4.80 million) vs A$7.5 million last year
** 298,576 shares change hands, 2.4x the 30-day average of 126,982 shares
** Stock flat YTD, including moves in day's session
($1 = 1.6054 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((Jasmeenaraislam.shaikh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.